During the past decade, Synexus- Chandler conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 7 clinical trials were completed, i.e. on average, 30.4% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 7 clinical trials were completed. i.e. 41.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Synexus- Chandler" #1 sponsor was "Eli Lilly and Company" with 13 trials, followed by "Rhythm Pharmaceuticals, Inc." with 3 trials sponsored, "Allergan" with 2 trials sponsored, "Janssen Vaccines & Prevention B.V." with 2 trials sponsored and "Boston Pharmaceuticals" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Synexus- Chandler" #1 collaborator was "Advaccine (Suzhou) Biopharmaceuticals Co., Ltd." with 1 trials as a collaborator and "Brigham and Women's Hospital" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Synexus- Chandler" are "Diabetic Peripheral Neuropathic Pain" (4 trials), "Chronic Low-back Pain" (3 trials), "Osteoarthritis" (3 trials), "Episodic Migraine" (2 trials) and "Respiratory Syncytial Viruses" (2 trials). Many other conditions were trialed in "Synexus- Chandler" in a lesser frequency.

Most popular intervention types in "Synexus- Chandler" are "Drug" (20 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "LY3016859" (3 trials), "LY3556050" (3 trials), "Atogepant" (2 trials) and "LY3526318" (2 trials). Other intervention names were less common.

The vast majority of trials in "Synexus- Chandler" are 23 trials for "All" genders.

Currently, there are NaN active trials in "Synexus- Chandler". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 14 completed trials in Synexus- Chandler, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Synexus- Chandler, 0 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".